PGI conducts awareness programme for scleroderma
Prof. Shefali K Sharma said that The Clinical Immunology and Rheumatology unit in the Department of Internal Medicine is involved in extensive research of the disease and many drugs have been repurposed and have been found to be useful.
The Department of Internal Medicine, PGIMER, Chandigarh, has recently organised a scleroderma Patient Awareness Programme which was attended by over 150 patients.
Dr. Chandershekhar, President elect of Indian Rheumatology Association from Bangalore was invited as the speaker for the session. He spoke to the patients about the various manifestations of the disease and how to cope with its course and complications. He said, “The first step is to accept the disease and then to comply with the treatment as advised by the specialist”.
Prof. Shefali K Sharma said that The Clinical Immunology and Rheumatology unit in the Department of Internal Medicine is involved in extensive research of the disease and many drugs have been repurposed and have been found to be useful.
A panel of doctors from the department, Dr Aman Sharma, Dr Varun Dhir, and Dr Shankar Naidu answered the queries of patients.
Sharma introduced the patients to the website, http://www.sclerodermaindia.com, and said it is an attempt to increase awareness about Scleroderma.
“The key is early diagnosis and in the last two decades there has been tremendous evolvement in treatment modalities which have led to better quality of life for patients.We want this website to work as an interface between doctors and patients and help patients to understand the disease, accelerate the diagnosis and understand that there are others also suffering from the disease. We also have a WhatsApp group to address the issues of patients,” said Sharma.
A detailed discussion revealed critical information on various aspects of Sclerosis.
Comments are closed.